Neonatal Early-Onset Sepsis Due to Haemophilus Influenzae in Utah.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
01 03 2023
Historique:
pubmed: 3 2 2023
medline: 25 2 2023
entrez: 2 2 2023
Statut: ppublish

Résumé

Haemophilus influenzae causes serious invasive disease in children and is described as an infrequent cause of neonatal early-onset sepsis (EOS). Here we present the clinical and microbiologic features of 10 cases of EOS due to H. influenzae in Utah.

Identifiants

pubmed: 36729883
doi: 10.1097/INF.0000000000003795
pii: 00006454-202303000-00024
pmc: PMC10088353
mid: NIHMS1882814
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e90-e92

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD047349
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002538
Pays : United States

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

A.J.B. has intellectual property licensed to BioFire Diagnostics and receives royalties through the University of Utah. A.J.B. collaborates with BioFire Diagnostics, LLC on federally funded studies and has received research funding from BioFire Diagnostics for investigator-initiated research. A.J.B. has acted as a paid advisor to BioFire Diagnostics and Merck & Co., Inc. The other authors have no conflicts of interest to disclose.

Références

Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev. 2014;27:21–47.
Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013.
Stoll BJ, Puopolo KM, Hansen NI, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Early-onset neonatal sepsis 2015 to 2017, the rise of Escherichia coli , and the need for novel prevention strategies. JAMA Pediatr. 2020;174:e200593.
Collins S, Ramsay M, Slack MP, et al. Risk of invasive Haemophilus influenzae infection during pregnancy and association with adverse fetal outcomes. JAMA. 2014;311:1125–1132.
MacNeil JR, Cohn AC, Farley M, et al. Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008. Clin Infect Dis. 2011;53:1230–1236.
Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011;30:937–941.
Flannery DD, Puopolo KM, Hansen NI, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Antimicrobial susceptibility profiles among neonatal early-onset sepsis pathogens. Pediatr Infect Dis J. 2022;41:263–271.
Collins S, Litt DJ, Flynn S, et al. Neonatal invasive Haemophilus influenzae disease in England and Wales: epidemiology, clinical characteristics, and outcome. Clin Infect Dis. 2015;60:1786–1792.
Bender JM, Cox CM, Mottice S, et al. Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis. 2010;50:e41–e46.
Crandall H, Christiansen J, Varghese AA, et al. Clinical and molecular epidemiology of invasive Haemophilus influenzae serotype a infections in Utah children. J Pediatric Infect Dis Soc. 2020;9:650–655.
Mukhopadhyay S, Puopolo KM. Risk assessment in neonatal early onset sepsis. Semin Perinatol. 2012;36:408–415.
Johnson DM, Sader HS, Fritsche TR, et al. Susceptibility trends of Haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2003;47:373–376.
Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial susceptibility survey of invasive Haemophilus influenzae in the United States in 2016. Microbiol Spectr. 2022;10:e0257921.

Auteurs

Alyssa Varghese (A)

From the Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.
University of Texas Medical Branch School of Medicine, Galveston, Texas.

Anne J Blaschke (AJ)

From the Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.

Ernest Kent Korgenski (EK)

From the Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.
Department of Pediatrics' Research Enterprise, Pediatric Clinical Program, Intermountain Health Care, Salt Lake City.

Hillary Crandall (H)

Division of Pediatric Critical Care, University of Utah School of Medicine, Salt Lake City, Utah.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH